Neo-kidney augment

BIOLOGICAL2 trials

Sponsors

Tengion, Prokidney

Conditions

Chronic Kidney DiseaseType 2 Diabetes

Phase 1

A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes

TerminatedNCT02008851

TengionChronic Kidney Disease

Start: 2013-12-31End: 2014-12-31Updated: 2014-12-11

Phase 2

Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)

TerminatedNCT02525263

ProkidneyChronic Kidney Disease, Type 2 Diabetes

Start: 2016-07-31End: 2017-08-31Updated: 2021-04-23